genOway
Frederic Putinier is an accomplished operations executive with extensive experience in research and development, innovation, and project management within the biotechnology and materials industries. Currently serving as Director of Operations (COO) at genOway since April 2024, Frederic manages six technical departments and oversees a team of 70 individuals. Prior roles include Design & Laboratory Manager at NEMERA, where Frederic led a team of 20 in medical device development, and Director of R&D at ORAPI GROUP, where Frederic was involved in strategic planning and multi-functional project coordination. Frederic's earlier positions include leading innovation at Gerflor and Mapa Spontex. Frederic holds an engineering degree in Chemistry, Polymers, and Materials from ITECH Lyon, as well as various project management and operational excellence certifications.
This person is not in any teams
genOway
1 followers
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.